Manhattan Scients (MHTX) 0.0640 $MHTX
Ex-GE Healthcare CTO Michael J. Harsh Joins Manhattan Scientifics Advisory Board
BusinessWire - Tue Mar 29, 8:00AM CDT
Manhattan Scientifics, Inc. (MHTX: OTCQB) announced today that Michael J. Harsh, former VP & Chief Technology Officer for GE Healthcare and a recognized global expert on medical imaging technology, has joined the Company's Science and Technology Advisory Board.
Senior Scientific Teams Up With University of Michigan On In Vivo Breast Cancer Diagnostic
BusinessWire - Wed Jan 13, 8:00AM CST
Manhattan Scientifics, Inc. (OTCQB: MHTX) announced today that its Senior Scientific unit, developing a platform for the early detection of cancer and other human diseases, has established a Research Collaboration with The University of Michigan Medical School. The collaboration's goal is to demonstrate the applicability of the company's magnetic relaxometry technology for diagnosing and staging breast cancers.
Senior Scientific Extends Collaboration with MD Anderson Cancer Center
BusinessWire - Mon Dec 14, 8:00AM CST
Manhattan Scientifics, Inc. (OTCQB: MHTX) announced today that its Senior Scientific, LLC unit, developing a platform for the early detection of cancer and other human diseases, has renewed its Collaboration Agreement with The University of Texas MD Anderson Cancer Center, establishing a multi-year program with extended scope. The agreement calls for MD Anderson to participate in a rigorous development program to translate the pre-clinical research to first use in humans.
Manhattan Scientifics Announces Chinese Patent Issued for the Early Cancer Detection Technology Platform
BusinessWire - Mon Oct 26, 8:36AM CDT
Senior Scientific, LLC, a unit of Manhattan Scientifics (MHTX: OTCQB) and a developer of nanobiotechnology for the early detection and localization of cancer and other human diseases, today announced that the Company has recently been granted a patent by the Chinese Patent Office, Patent No. CN102695473 A, covering the "Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof." This patent is an additional patent granted for its MRX(TM) cancer detection technology that has been granted and issued in by the U.S. Patent office under U.S. Patent No. US 9,095,270 B2.
Manhattan Scientifics Announces Issuance of Additional Patent Covering Detection and Imaging of Cancer Cells
BusinessWire - Mon Aug 10, 8:00AM CDT
Manhattan Scientifics, Inc. (OTCQB:MHTX) announced today that its Senior Scientific, LLC unit, a nanobiotechnology company for the early detection and localization of cancer and other human diseases, has been granted an additional United States Patent for its MRX(TM) cancer detection technology. U.S. Patent No. US 9,095,270 B2 entitled "Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof." The patent provides a method as well as an apparatus for detecting and measuring cancer cells, using magnetic nanoparticles.
Manhattan Scientifics Engages Services of Torreya Partners
BusinessWire - Thu Jul 16, 8:00AM CDT
Manhattan Scientifics, Inc. (MSI) (OTCQB:MHTX) today announced the engagement of Torreya Partners and its professional services sister company, Torreya Insights.
Manhattan Scientifics Issues Letter from the New President of its Senior Scientific Subsidiary
BusinessWire - Fri May 08, 8:53AM CDT
Manhattan Scientifics, Inc. (MSI) (OTCQB: MHTX) released a Letter from the New President of Senior Scientific LLC that was filed as an 8k with the U.S. Securities and Exchange Commission.
Manhattan Scientifics Issues Letter to Shareholders
BusinessWire - Mon Apr 20, 10:14AM CDT
Manhattan Scientifics, Inc. (MSI) (OTCQB:MHTX) released a Letter to Shareholders today that was filed as an 8k with the U.S. Securities and Exchange Commission.
Manhattan Scientifics Announces Return of Marvin Maslow as Chairman of the Board
BusinessWire - Wed Mar 25, 8:00AM CDT
Manhattan Scientifics, Inc. (MSI) (OTCQB: MHTX) announced today that Marvin Maslow, founder of MSI, has re-joined the Company's Board of Directors as Chairman.
Manhattan Scientifics to Immediately Receive $8 Million as it Reacquires its Nano-Structured Metals Technology and Related Intellectual Property and Equipment
BusinessWire - Wed Feb 18, 8:15AM CST
Manhattan Scientifics, Inc. (OTCQB: MHTX) has reacquired all rights in its nano-structured metals technology from its former Licensee whose strategic corporate priorities had changed. The agreement includes a one-time payment to Manhattan of $8 million, the assignment to Manhattan of all related IP and the transfer of ownership of various ECAP machinery and equipment used in the manufacturing process of nano-structured metals. The additional non-cash value of this transaction exceeds $10 million.
Manhattan Scientifics Recruits Robert R. Proulx as Its New President and Chief Operating Officer for Its Senior Scientific Subsidiary
BusinessWire - Wed Jan 14, 8:00AM CST
Manhattan Scientifics, Inc. (OTCQB:MHTX) has recruited Robert R. Proulx (pronounced "Pru"
to the position of President and Chief Operating Officer of its Senior Scientific LLC subsidiary, effective January 12. As previously announced, Gerald Grafe, former president of Senior Scientific, is remaining with Senior Scientific to focus on strategic relationships and intellectual property issues. Edward R. Flynn, PhD, founder of Senior Scientific, is remaining as Chief Scientist.
Manhattan Scientifics Announces Expansion of Executive Team at Its Senior Scientific Subsidiary
BusinessWire - Tue Dec 30, 10:00AM CST
Manhattan Scientifics, Inc. (OTCQB:MHTX) is recruiting a seasoned executive to oversee Senior Scientific's next stage of product development for its MRX diagnostic technology for the early detection of cancer. The new President and COO candidate under consideration, has a strong background in the life sciences and experience in diagnostic medical product development. The new President/COO will be responsible for expanding the collaborations in place with the MD Anderson Cancer Center in Houston and The University of New Mexico Health Sciences Center, Albuquerque, to help further develop this technology.
Manhattan Scientifics raises USD2.0m equity
M2 - Mon Nov 24, 8:15AM CST
Manhattan Scientifics, Inc. (OTC: MHTX) said it has completed a USD2.0 million equity raise.
Manhattan Scientifics Completes $2.0 Million Equity Raise
BusinessWire - Fri Nov 21, 8:00AM CST
Manhattan Scientifics, Inc. (OTCQB:MHTX) (the "Company" has completed a $2.0 million equity raise. Details of the raise are available in the Company's November 18th 8K filing with the SEC. The proceeds will primarily be used to fund the advancement, demonstration and validation of its MRX cancer diagnostic technology under development by its subsidiary, Senior Scientific, LLC.
Manhattan Scientifics Engages Dian Griesel Int'l.
BusinessWire - Thu Oct 30, 6:45AM CDT
Manhattan Scientifics, Inc. (OTCQB: MHTX) has engaged Dian Griesel Int'l. (DGI) to manage media relations. DGI will work toward the objective of increasing awareness of the company and its subsidiary Senior Scientific LLC, which has developed and patented technologies that use bio safe nanoparticles and sensitive magnetic sensors to detect and measure cancer cells more rapidly and less expensively than current methods.
SeeThruEquity Issues Company Note on Manhattan Scientifics, Highlighting MRX Technology Featured in MD Anderson Presentation
ACCESSWIRE - Mon Oct 13, 8:00AM CDT
New York, NY / ACCESSWIRE / October 13, 2014 / SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued a company note on Manhattan Scientifics, Inc. (OTCQB: MHTX).
Manhattan Scientifics' Unparalleled Cancer Measurement Technology Featured in MD Anderson Presentation
BusinessWire - Wed Oct 08, 7:49AM CDT
Senior Scientific LLC, a subsidiary of Manhattan Scientifics, Inc. (OTCQB: MHTX), is currently collaborating with The University of Texas MD Anderson Cancer Center (MDACC) to advance, demonstrate and validate a cancer detection and measurement technology originally developed by Edward R. Flynn, PhD. John D. Hazle, PhD of the MD Anderson Cancer Center recently presented initial results from the collaboration in a poster at the World Molecular Imaging Conference in Seoul, South Korea. The link to the results can be found here - http://www.mhtx.com/wmic/2014-poster.pdf.
Manhattan Scientifics Issues Follow up Report to Shareholders -"Pushing the Limits of Cancer Detection"
BusinessWire - Thu Oct 02, 7:28AM CDT
Three months ago Manhattan Scientifics (OTCQB: MHTX) announced the delivery of its 1st breakthrough cancer measurement instrument to M.D. Anderson Cancer Center in Houston.
Ex-GE Healthcare CTO Michael J. Harsh Joins Manhattan Scientifics Advisory Board
BusinessWire - Tue Mar 29, 8:00AM CDT
Manhattan Scientifics, Inc. (MHTX: OTCQB) announced today that Michael J. Harsh, former VP & Chief Technology Officer for GE Healthcare and a recognized global expert on medical imaging technology, has joined the Company's Science and Technology Advisory Board.
Senior Scientific Teams Up With University of Michigan On In Vivo Breast Cancer Diagnostic
BusinessWire - Wed Jan 13, 8:00AM CST
Manhattan Scientifics, Inc. (OTCQB: MHTX) announced today that its Senior Scientific unit, developing a platform for the early detection of cancer and other human diseases, has established a Research Collaboration with The University of Michigan Medical School. The collaboration's goal is to demonstrate the applicability of the company's magnetic relaxometry technology for diagnosing and staging breast cancers.
Senior Scientific Extends Collaboration with MD Anderson Cancer Center
BusinessWire - Mon Dec 14, 8:00AM CST
Manhattan Scientifics, Inc. (OTCQB: MHTX) announced today that its Senior Scientific, LLC unit, developing a platform for the early detection of cancer and other human diseases, has renewed its Collaboration Agreement with The University of Texas MD Anderson Cancer Center, establishing a multi-year program with extended scope. The agreement calls for MD Anderson to participate in a rigorous development program to translate the pre-clinical research to first use in humans.
Manhattan Scientifics Announces Chinese Patent Issued for the Early Cancer Detection Technology Platform
BusinessWire - Mon Oct 26, 8:36AM CDT
Senior Scientific, LLC, a unit of Manhattan Scientifics (MHTX: OTCQB) and a developer of nanobiotechnology for the early detection and localization of cancer and other human diseases, today announced that the Company has recently been granted a patent by the Chinese Patent Office, Patent No. CN102695473 A, covering the "Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof." This patent is an additional patent granted for its MRX(TM) cancer detection technology that has been granted and issued in by the U.S. Patent office under U.S. Patent No. US 9,095,270 B2.
Manhattan Scientifics Announces Issuance of Additional Patent Covering Detection and Imaging of Cancer Cells
BusinessWire - Mon Aug 10, 8:00AM CDT
Manhattan Scientifics, Inc. (OTCQB:MHTX) announced today that its Senior Scientific, LLC unit, a nanobiotechnology company for the early detection and localization of cancer and other human diseases, has been granted an additional United States Patent for its MRX(TM) cancer detection technology. U.S. Patent No. US 9,095,270 B2 entitled "Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof." The patent provides a method as well as an apparatus for detecting and measuring cancer cells, using magnetic nanoparticles.
Manhattan Scientifics Engages Services of Torreya Partners
BusinessWire - Thu Jul 16, 8:00AM CDT
Manhattan Scientifics, Inc. (MSI) (OTCQB:MHTX) today announced the engagement of Torreya Partners and its professional services sister company, Torreya Insights.
Manhattan Scientifics Issues Letter from the New President of its Senior Scientific Subsidiary
BusinessWire - Fri May 08, 8:53AM CDT
Manhattan Scientifics, Inc. (MSI) (OTCQB: MHTX) released a Letter from the New President of Senior Scientific LLC that was filed as an 8k with the U.S. Securities and Exchange Commission.
Manhattan Scientifics Issues Letter to Shareholders
BusinessWire - Mon Apr 20, 10:14AM CDT
Manhattan Scientifics, Inc. (MSI) (OTCQB:MHTX) released a Letter to Shareholders today that was filed as an 8k with the U.S. Securities and Exchange Commission.
Manhattan Scientifics Announces Return of Marvin Maslow as Chairman of the Board
BusinessWire - Wed Mar 25, 8:00AM CDT
Manhattan Scientifics, Inc. (MSI) (OTCQB: MHTX) announced today that Marvin Maslow, founder of MSI, has re-joined the Company's Board of Directors as Chairman.
Manhattan Scientifics to Immediately Receive $8 Million as it Reacquires its Nano-Structured Metals Technology and Related Intellectual Property and Equipment
BusinessWire - Wed Feb 18, 8:15AM CST
Manhattan Scientifics, Inc. (OTCQB: MHTX) has reacquired all rights in its nano-structured metals technology from its former Licensee whose strategic corporate priorities had changed. The agreement includes a one-time payment to Manhattan of $8 million, the assignment to Manhattan of all related IP and the transfer of ownership of various ECAP machinery and equipment used in the manufacturing process of nano-structured metals. The additional non-cash value of this transaction exceeds $10 million.
Manhattan Scientifics Recruits Robert R. Proulx as Its New President and Chief Operating Officer for Its Senior Scientific Subsidiary
BusinessWire - Wed Jan 14, 8:00AM CST
Manhattan Scientifics, Inc. (OTCQB:MHTX) has recruited Robert R. Proulx (pronounced "Pru"
to the position of President and Chief Operating Officer of its Senior Scientific LLC subsidiary, effective January 12. As previously announced, Gerald Grafe, former president of Senior Scientific, is remaining with Senior Scientific to focus on strategic relationships and intellectual property issues. Edward R. Flynn, PhD, founder of Senior Scientific, is remaining as Chief Scientist. Manhattan Scientifics Announces Expansion of Executive Team at Its Senior Scientific Subsidiary
BusinessWire - Tue Dec 30, 10:00AM CST
Manhattan Scientifics, Inc. (OTCQB:MHTX) is recruiting a seasoned executive to oversee Senior Scientific's next stage of product development for its MRX diagnostic technology for the early detection of cancer. The new President and COO candidate under consideration, has a strong background in the life sciences and experience in diagnostic medical product development. The new President/COO will be responsible for expanding the collaborations in place with the MD Anderson Cancer Center in Houston and The University of New Mexico Health Sciences Center, Albuquerque, to help further develop this technology.
Manhattan Scientifics raises USD2.0m equity
M2 - Mon Nov 24, 8:15AM CST
Manhattan Scientifics, Inc. (OTC: MHTX) said it has completed a USD2.0 million equity raise.
Manhattan Scientifics Completes $2.0 Million Equity Raise
BusinessWire - Fri Nov 21, 8:00AM CST
Manhattan Scientifics, Inc. (OTCQB:MHTX) (the "Company"
has completed a $2.0 million equity raise. Details of the raise are available in the Company's November 18th 8K filing with the SEC. The proceeds will primarily be used to fund the advancement, demonstration and validation of its MRX cancer diagnostic technology under development by its subsidiary, Senior Scientific, LLC. Manhattan Scientifics Engages Dian Griesel Int'l.
BusinessWire - Thu Oct 30, 6:45AM CDT
Manhattan Scientifics, Inc. (OTCQB: MHTX) has engaged Dian Griesel Int'l. (DGI) to manage media relations. DGI will work toward the objective of increasing awareness of the company and its subsidiary Senior Scientific LLC, which has developed and patented technologies that use bio safe nanoparticles and sensitive magnetic sensors to detect and measure cancer cells more rapidly and less expensively than current methods.
SeeThruEquity Issues Company Note on Manhattan Scientifics, Highlighting MRX Technology Featured in MD Anderson Presentation
ACCESSWIRE - Mon Oct 13, 8:00AM CDT
New York, NY / ACCESSWIRE / October 13, 2014 / SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued a company note on Manhattan Scientifics, Inc. (OTCQB: MHTX).
Manhattan Scientifics' Unparalleled Cancer Measurement Technology Featured in MD Anderson Presentation
BusinessWire - Wed Oct 08, 7:49AM CDT
Senior Scientific LLC, a subsidiary of Manhattan Scientifics, Inc. (OTCQB: MHTX), is currently collaborating with The University of Texas MD Anderson Cancer Center (MDACC) to advance, demonstrate and validate a cancer detection and measurement technology originally developed by Edward R. Flynn, PhD. John D. Hazle, PhD of the MD Anderson Cancer Center recently presented initial results from the collaboration in a poster at the World Molecular Imaging Conference in Seoul, South Korea. The link to the results can be found here - http://www.mhtx.com/wmic/2014-poster.pdf.
Manhattan Scientifics Issues Follow up Report to Shareholders -"Pushing the Limits of Cancer Detection"
BusinessWire - Thu Oct 02, 7:28AM CDT
Three months ago Manhattan Scientifics (OTCQB: MHTX) announced the delivery of its 1st breakthrough cancer measurement instrument to M.D. Anderson Cancer Center in Houston.
